Product Management Today - New gabapentin generic
Sunday, December 28th, 2008Apotex Inc (Weston, Ontario, Canada), has introduced its oral gabapentin generic. In prescription strengths of 600 mg and 800 mg, gabapentin is approved for use as adjunctive therapy for patients with epilepsy and for the treatment of postherpetic neuralgia.
Related Results
GabapentinGabapentin withdrawalIVAX Launches Gabapentin CapsulesBattle commences on generic…
